| The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues. | None |
| Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. | None |
| The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition. | None |
| Oncogenic transformation of normal enterocytes by overexpression of cyclin D1. | None |
| Results describe how patterns of gene expression in human tumors have been deconvoluted to reveal a mechanism of action for the cyclin D1 oncogene. | None |
| An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. | None |
| cyclin D1 can induce deregulation of the mitotic apparatus and aneuploidy, effects that could contribute to the role of this oncogene in malignancy | None |
| The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. | None |
| The cyclin D1b splice variant: an old oncogene learns new tricks. | None |
| Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. | None |
| A novel cyclin encoded by a bcl1-linked candidate oncogene. | None |
| Oncogenic virus-associated neoplasia: a role for cyclin D1 genotypes influencing the age of onset of disease?. | None |
| The results indicate that the waiting time for onset of oncogenic virus-associated neoplasia in patients homozygous (GG) for CCND1 genotypes (52 years) was 12 years earlier in comparison with patients carrying AG or AA genotypes (60 years). | None |
| The putative oncogene PRAD1 encodes a novel cyclin. | None |
| Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer. | None |
| Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity. | None |
| Coupled alteration of transcription and splicing by a single oncogene: boosting the effect on cyclin D1 activity. | None |
| A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. | None |
| Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater. | None |
| results show that human cyclin D1b has different biological functions than cyclin D1a and confirm its oncogenic properties | None |